FDA calendar · February 2022 · built from SEC filings

PDUFA dates February 2022: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in February 2022. The FDA calendar also recorded 11 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in February 2022

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

February 2022: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
Feb 2022Month disclosedPYRUKYND®AGIOFDA approval—ApprovedSEC Form 10-K
February 3, 2022Xigduo Xr (dapagliflozin; metformin hydrochloride)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
February 4, 2022KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
February 15, 2022Iclusig (ponatinib hydrochloride)TAKLabel expansion—ApprovedopenFDA Drugs@FDA
February 22, 2022—MENSNDA/BLA accepted—Completedsec_424b
February 25, 2022Acuvue Theravision With Ketotifen (ketotifen fumarate)JNJFDA approval—ApprovedopenFDA Drugs@FDA
February 28, 2022Yeztugo® (lenacapavir)GILDComplete Response Letter—CRL issuedFDA Complete Response Letters
February 28, 2022CARVYKTI (ciltacabtagene autoleucel)LEGNFDA approvalwith relapsed or refractory multiple myelomaApprovedSEC 8-K Exhibit 99.1
February 28, 2022ALUNBRIG (brigatinib)TAKLabel expansion—ApprovedopenFDA Drugs@FDA

February 2022: dated readouts

DateDrugCompanyEventIndicationStatusSource
Feb 2022Month disclosedsepofarsenPRQRTopline readout—Missed primary endpointSEC Form 10-K
Feb 2022Month disclosed—VALNTopline readout—PositiveSEC Form 10-K

Questions

What PDUFA dates are in February 2022?

0 PDUFA dates fell in February 2022. The FDA calendar also recorded 11 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.